Prior efforts profiling MTSCC tumors have shown that almost uniformly all MTSCC patients harbor dysregulation of the Hippo signaling pathway, including alterations in NF2, a feature also found in a subset of highly aggressive unclassified RCC tumors [27], as well as alterations in other Hippo-related genes. Here, NF2 is linked to renal cell carcinoma.